Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity GENETIC SIGNATURES LIMITED ABN/ARBN Financial year ended: 30 095 913 205 30 June 2026...
FY26 Appendix 4G and Corporate Governance Statement
Filed with ASX ·
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Genetic Signatures Ltd. on 6ix
Story so far
Earlier from Genetic Signatures
- FY26 Results Release
- FY26 Appendix 4E and Annual Report
- FY 26 Annual Results and Investor Webinar Notification
- Commercial Testing Commences at Hvidovre Hospital in Denmark
- GSS responds to the BCAL Diagnostics Announcement
Later from Genetic Signatures
- FY26 Market Update
- Change in substantial holding
- Change in Substantial Shareholder Notice for GSS
- Genetic Signatures and Microba in Merger Discussions
- Ceasing to be a substantial holder
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures